Eli Lilly Y Cia De Mexico S.A. de C.V.

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 9.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Spanish Format: PDF Download Buy full report

What’s included?

This report extracts all available information about this company from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Calle Barranca Del Muerto 329-1, Col. San Jose Insurgentes
Mexico City; Federal District of Mexico City; Map
Postal Code: 03900

Tel: +52 551719



Company Description
Eli Lilly Mexico S.A. de C.V., a subsidiary of Eli Lilly & Company, is a company dedicated to the pharmaceutical industry research and development of solutions for human health care in therapeutic areas including oncology and critical care, neurosciences, cardiology, endocrinology, diabetes, infectious disease and erectile dysfunction as well as in animal health areas. The company began operations in Mexico in 1943.
NAICS Industry Classification
Basic Information
Key Executives
Ownership Details

You’re in good company

EMIS company reports are used extensively by the world’s biggest companies, financial institutions, professional service companies and universities to assess businesses in emerging markets.


company profiles

We have information on both public and private companies across 125 countries.



EMIS is the go-to information source on emerging market companies for the world’s most prestigious businesses.

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

Contact us to learn more about our business solutions.
Sign up to our newsletter

Make sure you’re not the last to know by getting the latest insights on emerging markets straight to your inbox.